Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - tadalafil, quantity: 20 mg - tablet - excipient ingredients: titanium dioxide; purified talc; magnesium stearate; hypromellose; poloxamer; microcrystalline cellulose; croscarmellose sodium; triacetin; sodium lauryl sulfate; iron oxide yellow; lactose - tadalafil-rz is indicated for the treatment of:,? erectile dysfunction (ed) in adult males.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - tadalafil, quantity: 20 mg - tablet - excipient ingredients: microcrystalline cellulose; sodium lauryl sulfate; hyprolose; croscarmellose sodium; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; triacetin; iron oxide yellow - cipla tadalafil is indicated for the treatment of: ? erectile dysfunction (ed) in adult males ? moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 10 mg - tablet, film coated - excipient ingredients: povidone; croscarmellose sodium; sodium lauryl sulfate; lactose monohydrate; hyprolose; magnesium stearate; silicon dioxide; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000 - tadalafil rrh is indicated for the treatment of: - erectile dysfunction (ed) in adult males; - moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hyprolose; povidone; croscarmellose sodium; silicon dioxide; sodium lauryl sulfate; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000 - tadalafil tih is indicated for the treatment of: - erectile dysfunction (ed) in adult males; - moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 10 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; croscarmellose sodium; povidone; hyprolose; silicon dioxide; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000 - tadalafil arw is indicated for the treatment of: - erectile dysfunction (ed) in adult males; - moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 2.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium lauryl sulfate; povidone; hyprolose; lactose monohydrate; croscarmellose sodium; silicon dioxide; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000 - tadalafil tih is indicated for the treatment of: - erectile dysfunction (ed) in adult males; - moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; silicon dioxide; povidone; lactose monohydrate; hyprolose; sodium lauryl sulfate; croscarmellose sodium; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000 - tadalafil arw is indicated for the treatment of: - erectile dysfunction (ed) in adult males; - moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 2.5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; sodium lauryl sulfate; lactose monohydrate; silicon dioxide; hyprolose; povidone; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000 - tadalafil arw is indicated for the treatment of: - erectile dysfunction (ed) in adult males; - moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 2.5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; silicon dioxide; lactose monohydrate; sodium lauryl sulfate; hyprolose; magnesium stearate; povidone; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000 - tadalafil rrh is indicated for the treatment of: - erectile dysfunction (ed) in adult males; - moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - tadalafil, quantity: 5 mg - tablet, film coated - excipient ingredients: silicon dioxide; magnesium stearate; lactose monohydrate; croscarmellose sodium; hyprolose; povidone; sodium lauryl sulfate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000 - tadalafil tih is indicated for the treatment of: - erectile dysfunction (ed) in adult males; - moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males